Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Intraocular illumination – opportunities and risks of novel approaches

Frank H J Koch; Svenja Deuchler; Christian Lingenfelder; Phillip koelbl; Nicole Siebert; Robin Haag; Denise Sinning; Pankaj Singh; Thomas Kohnen; Martin hessling

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3621. doi:

ARVO Annual Meeting Abstract June 2021

Efficiency of simulation in combination with independent online learning within the framework of "EyesiNet" in ophthalmology education

Svenja Deuchler; Christina Sebode; Hanns Ackermann; Ingo Schmack; Pankaj Singh; Thomas Kohnen; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3620. doi:

ARVO Annual Meeting Abstract June 2020

The impact of changes at the vireoretinal interface and retinal thickness following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) device, implanted after partial PPV in patients with persistent or recurrent DME – results from the ILUVIT study, a single center, phase IV study.

Frank H J Koch; Pankaj Singh; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Svenja Deuchler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4870. doi:

ARVO Annual Meeting Abstract June 2020

Reduced vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant in patients with persistent or recurrent DME – results from the ILUVIT study.

Svenja Deuchler; Pankaj Singh; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4873. doi:

ARVO Annual Meeting Abstract June 2020

The correlation between the expression of cytokines and growth factors and the clinical stage of diabetic retinopathy in patients with DME – results from the ILUVIT study, a single center, phase IV study.

Pankaj Singh; Svenja Deuchler; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4879. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy and safety outcomes following the use of ILUVIEN in vitrectomized eyes – results from the University Eye Clinic Frankfurt in Germany

Frank H J Koch; Pankaj Singh; Adonis Chedid; Michael Mueller; Thomas Kohnen; Svenja K Deuchler

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2794. doi:

ARVO Annual Meeting Abstract June 2017

Important issues to reduce the retinal redetachment rate after vitrectomy with temporary silicone oil tamponade

Svenja Deuchler; Pankaj Singh; Michael Mueller; Thomas Kohnen; Clemens Wagner; Markus Schill; hanns Ackermann; Joerg Iwanczuk; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2813. doi:

ARVO Annual Meeting Abstract June 2017

The use of intravitreal implant ILUVIEN ® (fluocinolone acetonide) after prior OZURDEX ® Implant (DEX) (Dexamathason) in patients with diabetic macular edema (DME) - Efficacy and safety outcomes from the University Eye Clinic in Frankfurt, Germany

Pankaj Singh; Adonis Chedid; Svenja Deuchler; Thomas Kohnen; Michael Mueller; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2818. doi:

ARVO Annual Meeting Abstract September 2016

Simulated vitreoretinal surgery to prepare for real surgery

Frank H J Koch; Clemens Wagner; Pankaj Singh; Michael Mueller; Rachid Benjilali; Markus Schill; Hanns Ackermann; Dimitra Bon; Benjamin Schoene; Michael Koss; Svenja Deuchler

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1076. doi:

ARVO Annual Meeting Abstract September 2016

Interaction between lens transparency loss and retinal reattachment surgery with preliminary silicone oil fill

Svenja Deuchler; Pankaj Singh; Michael Mueller; Thomas Kohnen; Hanns Ackermann; Joerg Iwanczuk; Rachid Benjilali; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1078. doi:

ARVO Annual Meeting Abstract September 2016

Chromovitrectomy with Vitreodyne™.

Pankaj Singh; Svenja Deuchler; Michael Mueller; Thomas Kohnen; Diego Sousa-Martins; Beatriz Pinheiro-Torres; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4452. doi:

ARVO Annual Meeting Abstract June 2015

Extraocular non-invasive transscleral LED-Endoilluminator for Eye Speculum Integration

Frank H J Koch; Philipp Simon Koelbl; Christoph Lindner; Maximillian Bader; Svenja Deuchler; Pankaj Singh; Adonis Chedid De Robaulx; Christian Lingenfelder; Martin Hessling

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):381. doi:

ARVO Annual Meeting Abstract June 2015

Can the daily condition of the surgeon be measured in simulated surgery ?

Svenja Deuchler; Clemens Wagner; Pankaj Singh; Rami Al-Dwairi; michael mueller; Rachid Benjilali; Adonis Chedid De Robaulx; Thomas Kohnen; Markus Schill; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5125. doi:

ARVO Annual Meeting Abstract June 2015

Evaluation of questionnaire of the medical students after implementing the Eyesi® Binocular Indirect Ophthalmoscope (EBIO) into the Ophthalmology Curriculum of medical students.

Pankaj Singh; Svenja Deuchler; michael mueller; Adonis Chedid De Robaulx; Markus Schill; Clemens Wagner; Thomas Kohnen; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):133. doi:

ARVO Annual Meeting Abstract April 2014

Peri- and intraoperative factors affecting the emulsification of silicone oil used for retinal re-attachment in complicated retinal detachments

Svenja Deuchler; Pankaj Singh; Michael Mueller; Thomas Kohnen; Frank HJ Koch

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2319. doi:

ARVO Annual Meeting Abstract April 2014

SOP for removal of PVD induced vitreous opacities

Frank HJ Koch; Svenja Deuchler; Pankaj Singh; Thomas Kohnen; Henrik Schaefer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2322. doi:

ARVO Annual Meeting Abstract April 2014

Indirect Ophthalmoscopy: Training with conventional hardware versus the Eyesi® indirect ophthalmoscopy simulator

Pankaj Singh; Svenja Deuchler; Henrik Schaefer; Stephanie Fassbender; Thomas Kohnen; Frank HJ Koch

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):279. doi:

ARVO Annual Meeting Abstract March 2012

Improved Retinal Re-attachment Rate In Complicated Retinal Detachments: What Parameters Have To Be Recalled Before Removing Silicone Oil From The Vitreous Cavity?

Svenja Deuchler; Pankaj Singh; Michael Koss; Rami Al-Dwairi; Marcel Pfister; Rachid Benjilali; Hanns Ackermann; Frank H. Koch

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2623. doi:

ARVO Annual Meeting Abstract March 2012

Quantitative Determination And Compression Of Intravitreal Cytokines In Drp, Rvo And Armd

Marcel S. Pfister; Michael Koss; Pankaj Singh; Svenja Deuchler; Hanns Ackermann; Frank Koch

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3795. doi:

ARVO Annual Meeting Abstract March 2012

Does Virtual Reality Training Affect The Vitreoretinal Performance In The Operating Room?

Frank H. Koch; Svenja Deuchler; Michael Koss; Rami Al-Dwairi; Marcel Pfister; Hanns Ackermann; Pankaj Singh

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3801. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Intraocular illumination – opportunities and risks of novel approaches

Efficiency of simulation in combination with independent online learning within the framework of "EyesiNet" in ophthalmology education

Reduced vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant in patients with persistent or recurrent DME – results from the ILUVIT study.

The correlation between the expression of cytokines and growth factors and the clinical stage of diabetic retinopathy in patients with DME – results from the ILUVIT study, a single center, phase IV study.

Efficacy and safety outcomes following the use of ILUVIEN in vitrectomized eyes – results from the University Eye Clinic Frankfurt in Germany

Important issues to reduce the retinal redetachment rate after vitrectomy with temporary silicone oil tamponade

The use of intravitreal implant ILUVIEN ® (fluocinolone acetonide) after prior OZURDEX ® Implant (DEX) (Dexamathason) in patients with diabetic macular edema (DME) - Efficacy and safety outcomes from the University Eye Clinic in Frankfurt, Germany

Simulated vitreoretinal surgery to prepare for real surgery

Interaction between lens transparency loss and retinal reattachment surgery with preliminary silicone oil fill

Chromovitrectomy with Vitreodyne™.

Extraocular non-invasive transscleral LED-Endoilluminator for Eye Speculum Integration

Can the daily condition of the surgeon be measured in simulated surgery ?

Evaluation of questionnaire of the medical students after implementing the Eyesi® Binocular Indirect Ophthalmoscope (EBIO) into the Ophthalmology Curriculum of medical students.

Peri- and intraoperative factors affecting the emulsification of silicone oil used for retinal re-attachment in complicated retinal detachments

SOP for removal of PVD induced vitreous opacities

Indirect Ophthalmoscopy: Training with conventional hardware versus the Eyesi® indirect ophthalmoscopy simulator

Improved Retinal Re-attachment Rate In Complicated Retinal Detachments: What Parameters Have To Be Recalled Before Removing Silicone Oil From The Vitreous Cavity?

Quantitative Determination And Compression Of Intravitreal Cytokines In Drp, Rvo And Armd

Does Virtual Reality Training Affect The Vitreoretinal Performance In The Operating Room?

To View More...

You must be signed into an individual account to use this feature.